AKAMIS BIO LIMITED

Company Number		06001442
Company ID Number		06001442
Date formed		2006-11-17
Country		UNITED KINGDOM
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Active
Lastest accounts		31/12/2022
Account next due		30/09/2024
Latest return		02/02/2016
Return next due		02/03/2017
Type of accounts		GROUP
VAT Number /Sales tax ID		GB921825333

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Companies with same name AKAMIS BIO LIMITED

The following companies were found which have the same name as AKAMIS BIO LIMITED. These may be the same company in different jurisdictions

		Registered address	Last known status	Formation date
	AKAMIS BIO INC	245 MAIN ST FL 2 CAMBRIDGE MA 02142	Active	Company formed on the 2023-03-30

Company Officers of AKAMIS BIO LIMITED

Current Directors

Officer	Role	Date Appointed
PRIYA MANDE	Company Secretary	2018-02-01
METTE KRISTINE AGGER	Director	2012-07-06
JOHN WILLIAM BEADLE	Director	2009-05-21
MATTHEW FOY	Director	2012-07-06
DUNCAN HIGGONS	Director	2017-09-27
IP2IPO SERVICES LIMITED	Director	2018-04-30
PRIYA MANDE	Director	2016-09-29
PAOLO PAOLETTI	Director	2011-11-23
CHARLES ROWLAND	Director	2017-09-27

Previous Officers

Officer	Role	Date Appointed	Date Resigned
DANIEL BACH	Director	2018-02-01	2018-04-30
MADELEINE KENNEDY	Company Secretary	2016-10-04	2018-02-01
METTE KIRSTINE AGGER	Director	2012-07-06	2017-11-30
MAINA BHAMAN	Director	2010-04-09	2017-11-30
MICHAEL MOORE	Director	2009-05-21	2017-11-30
CHARLES ROWLAND	Director	2017-09-27	2017-11-30
CHARLES STUART WEBB SWINGLAND	Director	2010-10-04	2017-11-30
THEODORA HAROLD	Company Secretary	2008-04-23	2016-10-04
PHILLIP JOHN L'HUILLIER	Director	2010-12-15	2012-07-06
MERCIA FUND MANAGEMENT (NOMINEES) LIMITED	Director	2010-12-15	2012-07-06
SIMON CHRISTOPHER KERR	Director	2009-03-16	2011-01-28
ANDREW JUSTIN STEWART COATS	Director	2007-09-24	2010-12-15
RALPH STEPHEN HARRIS	Director	2008-04-23	2009-02-20
KEITH STEPHEN BRAGMAN	Director	2007-09-24	2009-01-16
PHILIP POOLE WILSON	Director	2007-09-23	2009-01-16
DAVID JOHN CAVALLA	Director	2007-09-23	2008-10-06
DAVID JOHN CAVALLA	Company Secretary	2007-09-23	2008-04-23
RICHARD GARRAWAY	Director	2006-11-17	2008-01-23
WILLIAM RAYNER	Company Secretary	2006-11-17	2007-09-24

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
JOHN WILLIAM BEADLE	HYBRID BIOSYSTEMS LIMITED	Director	2008-09-01	CURRENT	1997-08-19	Active
CHARLES ROWLAND	ORCHARD THERAPEUTICS (EUROPE) LIMITED	Director	2018-06-01	CURRENT	2015-09-02	Active

More director information

Advertised Job Vacancies

Job Title	Location	Job description	Date posted
Clinical Study Manager	Abingdon	PsiOxus Therapeutics Ltd is an Oxford based biotechnology company developing novel therapeutics with a particular focus upon cancer....	2016-06-09
Finance Administration Manager	Abingdon	Key responsibilities may include but are not limited to:. SAGE maintenance and quality control (to include but not limited to the inputting of key invoices,...	2016-02-05

Jobs results powered by Indeed

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-04-02		Second filing of capital allotment of shares GBP35,492.95
2024-04-02		Second filing of capital allotment of shares GBP38,958.46
2024-02-05		CONFIRMATION STATEMENT MADE ON 02/02/24, WITH UPDATES
2023-10-10		08/10/23 STATEMENT OF CAPITAL GBP 38945.76
2023-10-05		DIRECTOR APPOINTED LARS GREDSTED
2023-10-04		APPOINTMENT TERMINATED, DIRECTOR METTE KRISTINE AGGER
2023-10-04		APPOINTMENT TERMINATED, DIRECTOR PAOLO PAOLETTI
2023-09-29		12/09/23 STATEMENT OF CAPITAL GBP 35480.25
2023-08-29		Appointment of Oakwood Corporate Secretary Limited as company secretary on 2023-07-10
2023-07-06		GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/22
2023-06-21		Notification of a person with significant control statement
2023-06-20		17/06/23 STATEMENT OF CAPITAL GBP 255245.05
2023-06-05		DIRECTOR APPOINTED DR CHRISTOPHER BOWDEN
2023-05-16		CESSATION OF IMPERIAL INNOVATIONS BUSINESSES LLP AS A PERSON OF SIGNIFICANT CONTROL
2023-05-16		CESSATION OF IP2IPO PORTFOLIO (GP) LIMITED AS A PERSON OF SIGNIFICANT CONTROL
2023-02-14		31/12/22 STATEMENT OF CAPITAL GBP 34588.95
2023-02-14		CONFIRMATION STATEMENT MADE ON 02/02/23, WITH UPDATES
2023-01-03		Company name changed psioxus therapeutics LIMITED\certificate issued on 03/01/23
2023-01-03		REGISTERED OFFICE CHANGED ON 03/01/23 FROM Psioxus House 4-10 the Quadrant Abingdon Science Park Abingdon OX14 3YS England
2023-01-03	AD01	REGISTERED OFFICE CHANGED ON 03/01/23 FROM Psioxus House 4-10 the Quadrant Abingdon Science Park Abingdon OX14 3YS England
2023-01-03	CERTNM	Company name changed psioxus therapeutics LIMITED\certificate issued on 03/01/23
2022-11-02	TM02	Termination of appointment of Priya Mande on 2022-10-28
2022-10-18	RES10	Resolutions passed: Resolution of allotment of securities
2022-10-18	RES01	ADOPT ARTICLES 18/10/22
2022-10-18	MEM/ARTS	ARTICLES OF ASSOCIATION
2022-09-21	TM01	APPOINTMENT TERMINATED, DIRECTOR PRIYA MANDE
2022-07-31	CH01	Director's details changed for Mr Howard E Davis on 2022-07-20
2022-07-14	AP01	DIRECTOR APPOINTED MR HOWARD E DAVIS
2022-05-06	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/21
2022-02-25	CS01	CONFIRMATION STATEMENT MADE ON 02/02/22, WITH UPDATES
2022-02-03		31/12/21 STATEMENT OF CAPITAL GBP 31451.85
2022-02-03	SH01	31/12/21 STATEMENT OF CAPITAL GBP 31451.85
2022-01-04		APPOINTMENT TERMINATED, DIRECTOR JOHN WILLIAM BEADLE
2022-01-04	TM01	APPOINTMENT TERMINATED, DIRECTOR JOHN WILLIAM BEADLE
2021-10-24	RES13	Resolutions passed: Other company business 29/09/2021 Resolution of allotment of securities
2021-10-06	SH01	30/09/21 STATEMENT OF CAPITAL GBP 31460.4
2021-07-24	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/20
2021-03-16	AP01	DIRECTOR APPOINTED MR ROBIN LEWIS LINCOLN
2021-03-02	CS01	CONFIRMATION STATEMENT MADE ON 02/02/21, WITH UPDATES
2021-03-02	PSC02	Notification of Ip2Ipo Portfolio (Gp) Limited as a person with significant control on 2019-09-16
2021-02-24	SH01	02/02/21 STATEMENT OF CAPITAL GBP 31451.85
2021-02-04	MEM/ARTS	ARTICLES OF ASSOCIATION
2021-02-04	RES10	Resolutions passed: Resolution of allotment of securities Resolution of removal of pre-emption rights Resolution of adoption of Articles of Association
2020-12-14	SH01	30/11/20 STATEMENT OF CAPITAL GBP 29582.48
2020-12-03	SH01	30/06/20 STATEMENT OF CAPITAL GBP 29442.78
2020-07-02	AP01	DIRECTOR APPOINTED DR EZRA COHEN
2020-07-02	CH01	Director's details changed for Mr J. Duncan Higgons on 2020-07-01
2020-03-17	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/19
2020-02-14	CS01	CONFIRMATION STATEMENT MADE ON 02/02/20, WITH UPDATES
2019-11-25	SH01	01/11/19 STATEMENT OF CAPITAL GBP 29339.88
2019-11-01	TM01	APPOINTMENT TERMINATED, DIRECTOR CHARLES ROWLAND JR
2019-10-09	SH01	16/09/19 STATEMENT OF CAPITAL GBP 23936.07
2019-07-10	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/18
2019-02-14	CS01	CONFIRMATION STATEMENT MADE ON 02/02/19, WITH UPDATES
2019-02-13	CH01	Director's details changed for Mr Duncan Higgons on 2018-12-31
2018-11-07	AP02	Appointment of Ip2Ipo Services Limited as director on 2018-04-30
2018-11-07	TM01	APPOINTMENT TERMINATED, DIRECTOR IP2IPO SERVICES LIMITED
2018-11-07	SH01	07/11/18 STATEMENT OF CAPITAL GBP 23093.66
2018-08-02	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/17
2018-07-26	LATEST SOC	26/07/18 STATEMENT OF CAPITAL;GBP 22048.31
2018-07-26	SH01	26/07/18 STATEMENT OF CAPITAL GBP 22048.31
2018-06-25	CH01	Director's details changed for Priya Mande on 2018-06-15
2018-06-04	CH02	Director's details changed for Ip2Ipo Limited on 2018-04-30
2018-05-15	AP02	Appointment of Ip2Ipo Limited as director on 2018-04-30
2018-05-15	TM01	APPOINTMENT TERMINATED, DIRECTOR DANIEL BACH
2018-02-06	LATEST SOC	06/02/18 STATEMENT OF CAPITAL;GBP 22048.31
2018-02-06	CS01	CONFIRMATION STATEMENT MADE ON 02/02/18, WITH UPDATES
2018-02-06	AP01	DIRECTOR APPOINTED MR DANIEL BACH
2018-02-02	TM02	APPOINTMENT TERMINATED, SECRETARY MADELEINE KENNEDY
2018-02-02	AP03	Appointment of Ms Priya Mande as company secretary on 2018-02-01
2018-02-02	TM02	APPOINTMENT TERMINATED, SECRETARY MADELEINE KENNEDY
2018-01-18	AP01	DIRECTOR APPOINTED MS METTE KRISTINE AGGER
2018-01-18	AP01	DIRECTOR APPOINTED MR CHARLES ROWLAND
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR CHARLES SWINGLAND
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR CHARLES SWINGLAND
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR CHARLES ROWLAND
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR MICHAEL MOORE
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR MAINA BHAMAN
2018-01-18	TM01	APPOINTMENT TERMINATED, DIRECTOR METTE AGGER
2017-12-08	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2017-12-08	RES01	ADOPT ARTICLES 23/11/2017
2017-10-26	AP01	DIRECTOR APPOINTED MR DUNCAN HIGGONS
2017-10-26	AP01	DIRECTOR APPOINTED MR CHARLES ROWLAND
2017-09-28	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/16
2017-08-21	SH10	NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES
2017-08-21	SH08	NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2017-08-21	LATEST SOC	21/08/17 STATEMENT OF CAPITAL;GBP 21011.71
2017-08-21	SH02	SUB-DIVISION 23/05/17
2017-05-31	AD01	REGISTERED OFFICE CHANGED ON 31/05/2017 FROM 154B BROOK DRIVE MILTON PARK ABINGDON OXFORDSHIRE OX14 4SD ENGLAND
2017-05-31	AD01	REGISTERED OFFICE CHANGED ON 31/05/2017 FROM 154B BROOK DRIVE MILTON PARK ABINGDON OXFORDSHIRE OX14 4SD ENGLAND
2017-03-15	AA01	PREVEXT FROM 30/11/2016 TO 31/12/2016
2017-03-15	AA01	PREVEXT FROM 30/11/2016 TO 31/12/2016
2017-03-14	CS01	CONFIRMATION STATEMENT MADE ON 02/02/17, WITH UPDATES
2017-03-14	CS01	CONFIRMATION STATEMENT MADE ON 02/02/17, WITH UPDATES
2016-10-27	LATEST SOC	27/10/16 STATEMENT OF CAPITAL;GBP 21011.71
2016-10-27	LATEST SOC	27/10/16 STATEMENT OF CAPITAL;GBP 21011.71
2016-10-27	SH01	01/10/16 STATEMENT OF CAPITAL GBP 21011.71
2016-10-27	SH01	01/10/16 STATEMENT OF CAPITAL GBP 21011.71
2016-10-18	TM02	APPOINTMENT TERMINATED, SECRETARY THEODORA HAROLD
2016-10-18	TM02	APPOINTMENT TERMINATED, SECRETARY THEODORA HAROLD
2016-10-18	AP01	DIRECTOR APPOINTED PRIYA MANDE
2016-10-18	AP01	DIRECTOR APPOINTED PRIYA MANDE
2016-10-17	AP03	SECRETARY APPOINTED MADELEINE KENNEDY
2016-10-17	AP03	SECRETARY APPOINTED MADELEINE KENNEDY
2016-09-26	SH01	08/08/16 STATEMENT OF CAPITAL GBP 19215.91
2016-09-26	SH01	08/08/16 STATEMENT OF CAPITAL GBP 19215.91
2016-08-31	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/15
2016-08-31	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/15
2016-04-12	SH01	15/02/16 STATEMENT OF CAPITAL GBP 17183.11
2016-04-12	SH01	15/02/16 STATEMENT OF CAPITAL GBP 17183.11
2016-04-02	LATEST SOC	02/04/16 STATEMENT OF CAPITAL;GBP 16741.51
2016-04-02	AR01	02/02/16 FULL LIST
2015-07-29	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/14
2015-07-10	LATEST SOC	10/07/15 STATEMENT OF CAPITAL;GBP 16741.51
2015-07-10	SH01	01/06/15 STATEMENT OF CAPITAL GBP 16741.51
2015-07-10	SH01	31/05/15 STATEMENT OF CAPITAL GBP 15661.51
2015-06-22	SH01	18/05/15 STATEMENT OF CAPITAL GBP 15343.61
2015-06-10	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2015-06-10	RES01	ADOPT ARTICLES 18/05/2015
2015-03-16	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR CHARLES STUART WEBB SWINGLAND / 01/02/2015
2015-03-03	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR CHARLES STUART WEBB SWINGLAND / 01/02/2015
2015-03-02	AR01	02/02/15 FULL LIST
2014-10-23	SH01	10/10/14 STATEMENT OF CAPITAL GBP 13719.16
2014-06-02	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/13
2014-03-19	SH01	04/03/14 STATEMENT OF CAPITAL GBP 12448.58
2014-03-14	AR01	02/02/14 FULL LIST
2014-02-19	SH01	31/01/14 STATEMENT OF CAPITAL GBP 12398.58
2014-01-08	SH01	20/11/13 STATEMENT OF CAPITAL GBP 12139.88
2013-08-15	SH01	01/07/13 STATEMENT OF CAPITAL GBP 12064.88
2013-05-16	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/12
2013-03-26	AR01	02/02/13 FULL LIST
2013-02-26	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR JOHN BEADLE / 02/02/2013
2013-02-25	CH03	SECRETARY'S CHANGE OF PARTICULARS / MS THEODORA HAROLD / 02/02/2013
2013-01-07	AD01	REGISTERED OFFICE CHANGED ON 07/01/2013 FROM 5 NEW STREET SQUARE LONDON EC4A 3TW
2012-12-21	SH01	29/11/12 STATEMENT OF CAPITAL GBP 12061.88
2012-12-10	SH01	19/11/12 STATEMENT OF CAPITAL GBP 11141.48
2012-10-16	SH01	17/08/12 STATEMENT OF CAPITAL GBP 10957.68
2012-09-11	AP01	DIRECTOR APPOINTED MATTHEW FOY
2012-09-03	AP01	DIRECTOR APPOINTED METTE KIRSTINE AGGER
2012-08-20	SH01	06/07/12 STATEMENT OF CAPITAL GBP 10785.54
2012-08-08	RES01	ADOPT ARTICLES 06/07/2012
2012-07-26	TM01	APPOINTMENT TERMINATED, DIRECTOR MERCIA FUND MANAGEMENT (NOMINEES) LIMITED
2012-07-26	TM01	APPOINTMENT TERMINATED, DIRECTOR PHILLIP L'HUILLIER
2012-06-29	RES01	ADOPT ARTICLES 01/06/2012
2012-06-28	SH01	06/06/12 STATEMENT OF CAPITAL GBP 9512.82
2012-06-22	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/11
2012-05-29	SH01	20/04/12 STATEMENT OF CAPITAL GBP 8240.08
2012-03-28	AR01	02/02/12 FULL LIST
2012-03-28	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR JOHN BEADLE / 03/02/2011
2012-03-27	CH03	SECRETARY'S CHANGE OF PARTICULARS / MS THEODORA HAROLD / 03/03/2011
2012-03-22	MG01	PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1
2012-03-15	SH01	10/02/12 STATEMENT OF CAPITAL GBP 7994.18
2012-01-16	AP01	DIRECTOR APPOINTED DR PAOLO PAOLETTI
2012-01-10	SH01	23/11/11 STATEMENT OF CAPITAL GBP 7914.08
2011-11-21	MEM/ARTS	ARTICLES OF ASSOCIATION
2011-11-21	RES01	ALTER ARTICLES 10/11/2011
2011-06-23	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 30/11/10
2011-04-11	AP01	DIRECTOR APPOINTED DR PHILLIP JOHN L'HUILLIER
2011-04-11	SH01	25/03/11 STATEMENT OF CAPITAL GBP 7889.08
2011-04-07	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR JOHN BEADLE / 14/12/2010
2011-03-18	AR01	02/02/11 FULL LIST
2011-03-03	CH03	SECRETARY'S CHANGE OF PARTICULARS / MS THEODORA HAROLD / 14/12/2010
2011-03-03	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MAINA BHAMAN / 14/12/2010
2011-03-03	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR MICHAEL MOORE / 14/12/2010
2011-02-11	TM01	APPOINTMENT TERMINATED, DIRECTOR SIMON KERR
2011-01-17	AP02	CORPORATE DIRECTOR APPOINTED MERCIA FUND MANAGEMENT (NOMINEES) LIMITED
2011-01-11	MEM/ARTS	ARTICLES OF ASSOCIATION
2011-01-11	TM01	APPOINTMENT TERMINATED, DIRECTOR ANDREW COATS
2011-01-11	AD01	REGISTERED OFFICE CHANGED ON 11/01/2011 FROM 6 ALBERT STREET CAMBRIDGE CAMBS CB4 3BE
2011-01-11	SH01	15/12/10 STATEMENT OF CAPITAL GBP 7862.28
2011-01-06	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-01-05	RES15	CHANGE OF NAME 14/12/2010
2011-01-05	CERTNM	COMPANY NAME CHANGED MYOTEC THERAPEUTICS LTD. CERTIFICATE ISSUED ON 05/01/11
2011-01-05	CONNOT	NOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2010-10-27	AP01	DIRECTOR APPOINTED CHARLES STUART WEBB SWINGLAND
2010-06-23	AA	30/11/09 TOTAL EXEMPTION SMALL
2010-04-19	AP01	DIRECTOR APPOINTED MAINA BHAMAN
2010-03-23	CC04	STATEMENT OF COMPANY'S OBJECTS
2010-03-23	CC01	NOTICE OF RESTRICTION ON THE COMPANY'S ARTICLES
2010-03-23	RES01	ALTERATION TO MEMORANDUM AND ARTICLES 26/02/2010
2010-03-23	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2010-02-05	AR01	02/02/10 CHANGES
2009-11-24	AR01	17/11/09 FULL LIST
2009-11-23	CH01	DIRECTOR'S CHANGE OF PARTICULARS / SIMON CHRISTOPHER KERR / 17/11/2009
2009-11-23	CH01	DIRECTOR'S CHANGE OF PARTICULARS / PROFESSOR ANDREW JUSTIN STEWART COATS / 12/11/2009
2009-09-27	AA	30/11/08 TOTAL EXEMPTION SMALL
2009-09-22	RES09	AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL
2009-09-22	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2009-09-22	169	GBP IC 1685/1650 15/09/09 GBP SR 350@0.1=35
2009-07-14	123	NC INC ALREADY ADJUSTED 30/04/09
2009-07-14	RES13	DIR APPT 30/04/2009
2009-07-14	RES04	GBP NC 1200/6000 30/04/2009
2009-06-11	288a	DIRECTOR APPOINTED DR MICHAEL MOORE
2009-06-11	288a	DIRECTOR APPOINTED DR JOHN BEADLE
2009-04-08	288a	DIRECTOR APPOINTED SIMON CHRISTOPHER KERR
2009-03-04	288b	APPOINTMENT TERMINATED DIRECTOR RALPH HARRIS
2009-01-28	288b	APPOINTMENT TERMINATED DIRECTOR KEITH BRAGMAN
2009-01-28	288b	APPOINTMENT TERMINATED DIRECTOR PHILIP POOLE WILSON
2008-12-05	363a	RETURN MADE UP TO 17/11/08; FULL LIST OF MEMBERS

Industry Information

SIC/NAIC Codes

72 - Scientific research and development

721 - Research and experimental development on natural sciences and engineering

72110 - Research and experimental development on biotechnology

Licences & Regulatory approval

We could not find any licences issued to AKAMIS BIO LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

Fines / Sanctions

No fines or sanctions have been issued against AKAMIS BIO LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	1
Mortgages/Charges outstanding	1
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	0

Details of Mortgagee Charges

Charge Type	Date of Charge	Charge Status	Mortgagee
RENT SECURITY DEPOSIT DEED	2012-03-22	Outstanding	MEPC MILTON PARK NO.1 LIMITED AND MEPC MILTON PARK NO.2 LIMITED

Intangible Assets

Patents

We have not found any records of AKAMIS BIO LIMITED registering or being granted any patents

Domain Names

We do not have the domain name information for AKAMIS BIO LIMITED

Trademarks

We have not found any records of AKAMIS BIO LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for AKAMIS BIO LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as AKAMIS BIO LIMITED are:

Outgoings

Business Rates/Property Tax

No properties were found where AKAMIS BIO LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Import/Export of Goods

Goods imported/exported by AKAMIS BIO LIMITED

Date	Import Code	Imported Goods classification description
2018-12-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-12-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-12-00	84212980
2018-12-00	84212980
2018-11-00	84139100	Parts of pumps for liquids, n.e.s.
2018-11-00	84139100	Parts of pumps for liquids, n.e.s.
2018-08-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-08-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-07-00	30022000	Vaccines for human medicine
2018-07-00	30049000	Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2018-06-00	30049000	Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2018-06-00	84149000	Parts of : air or vacuum pumps, air or other gas compressors, fans and ventilating or recycling hoods incorporating a fan, n.e.s.
2018-06-00	84212100	Machinery and apparatus for filtering or purifying water
2018-06-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-06-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-04-00	84136080	Rotary positive displacement pumps, power-driven (excl. pumps of subheading 8413.11 and 8413.19, fuel, lubricating or cooling medium pumps for internal combustion piston engine, concrete pumps, gear pumps, vane pumps, screw pumps and hydraulic units)
2018-04-00	84139100	Parts of pumps for liquids, n.e.s.
2018-04-00	84212300	Oil or petrol-filters for internal combustion engines
2018-04-00	90278099	Non-electronic instruments and apparatus for physical or chemical analysis or for determining surface tension or the like, or for measuring heat or sound, n.e.s.
2018-03-00	84219990
2018-03-00	84219990
2018-03-00	90279080	Parts and accessories of microtomes or of gas or smoke analysis apparatus, n.e.s.
2018-03-00	90279080	Parts and accessories of microtomes or of gas or smoke analysis apparatus, n.e.s.
2018-02-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-02-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2018-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-09-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-08-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2016-07-00	30021010	Antisera
2016-07-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-07-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-07-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-01	30022000	Vaccines for human medicine
2015-06-00	30022000	Vaccines for human medicine
2015-05-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-05-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-02-01	30022000	Vaccines for human medicine
2015-02-00	30022000	Vaccines for human medicine
2014-12-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2014-09-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards

Technology Strategy Board Awards

AKAMIS BIO LIMITED has been awarded 1 awards from the Technology Strategy Board. The value of these awards is £ 1,727,687

Category	Award Date	Award/Grant
OCTAVE - Ovarian Cancer Trial with an Enhanced Group B Oncolytic Adenovirus : Feasibility Study	2013-02-01	£ 1,727,687

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards

The European Union has not awarded AKAMIS BIO LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

Last Datalog update:	2024-02-07 03:04:19
Primary Source:	Companies House

Company Overview

Company Officers of AKAMIS BIO LIMITED

Related Directorships